CROSARA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 957
EU - Europa 800
AS - Asia 393
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.161
Nazione #
US - Stati Uniti d'America 947
CN - Cina 274
IT - Italia 221
IE - Irlanda 190
SE - Svezia 156
TR - Turchia 63
FI - Finlandia 60
DE - Germania 45
AT - Austria 29
FR - Francia 24
BE - Belgio 19
GB - Regno Unito 19
IR - Iran 19
IN - India 12
UA - Ucraina 12
SG - Singapore 11
BR - Brasile 8
HU - Ungheria 6
TW - Taiwan 6
JP - Giappone 5
NL - Olanda 5
CA - Canada 4
MX - Messico 4
CH - Svizzera 3
RU - Federazione Russa 3
EE - Estonia 2
HN - Honduras 2
NO - Norvegia 2
QA - Qatar 2
A1 - Anonimo 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
RO - Romania 1
Totale 2.161
Città #
Chandler 207
Dublin 190
Ann Arbor 109
Ashburn 105
Beijing 71
Izmir 61
Dearborn 58
Nanjing 45
Parma 41
Princeton 36
Shanghai 26
Vienna 25
Los Angeles 24
Wilmington 22
Bremen 20
Shenyang 20
Brussels 18
Kunming 14
Milan 14
Boardman 13
Hebei 13
Sant'ilario D'enza 12
Mountain View 11
San Mateo 11
Fremont 10
Jacksonville 10
London 10
Changsha 9
Helsinki 9
Jinan 9
Nanchang 9
Woodbridge 9
Zanjan 9
New York 8
Jiaxing 7
São Paulo 7
Brescia 6
Chicago 6
Des Moines 6
Hefei 6
Ningbo 6
Pignone 6
Vicopisano 6
Washington 6
Abano Terme 5
Bougligny 5
Genoa 5
Monza 5
Preston City 5
Seattle 5
Zhengzhou 5
Chengdu 4
Düsseldorf 4
Guangzhou 4
Hangzhou 4
Sassuolo 4
Verona 4
Bari 3
Chieti 3
Haikou 3
Leawood 3
Magenta 3
Mexico City 3
Mumbai 3
New Taipei 3
Norwalk 3
Pune 3
Sacramento 3
San Lazzaro di Savena 3
Tianjin 3
Tokyo 3
Vaiano Cremasco 3
Wake Forest 3
Berlin 2
Bologna 2
Borås 2
Casanova Lonati 2
Catania 2
Doha 2
Frankfurt am Main 2
Fuzhou 2
Giessen 2
Houston 2
Lodi 2
Montreal 2
Nonantola 2
Oslo 2
Paderno Dugnano 2
Padova 2
Palermo 2
Pingtung City 2
Redwood City 2
Reggio Emilia 2
Reggio Nell'emilia 2
Rocklin 2
Rockville 2
Solaro 2
Tallinn 2
Toronto 2
West Jordan 2
Totale 1.481
Nome #
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 145
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 141
Transthoracic echocardiography in clinically healthy adult Newfoundland dogs: reference values for the breed 102
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 97
Tetralogia di Fallot in un gatto 87
Systolic Arterial Pressure Measured Simultaneously by Doppler Technique, Using Forelimb and Hindlimb in Dogs 86
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 81
Migration of a Kirschner wire to the heart in a Yorkshire terrier 68
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 65
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease 64
ECG of the month 63
Anatomic distribution and electrophysiologic properties of accessory atrioventricular pathways in dogs 56
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 54
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 54
Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease 54
Corner Diagnostico di Cardiologia 51
Screening for subaortic stenosis in Boxers in Italy 50
Miocardiopatie del cane 49
Endocardite batterica 48
Holter monitoring in 36 dogs with myxomatous mitral valve disease 47
Diagnostic performance of P wave duration in the identification of left atrial enlargement in dogs 47
Insufficienza cardiaca: fisiopatologia e principi di terapia 45
Malattia cronica mitralica 45
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 45
La malattia valvolare mitralica nel cane 44
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 43
Radiofrequency catheter ablation of concealed accessory pathways in two dogs with symptomatic atrioventricular reciprocating tachycardia 43
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 43
The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics 41
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 40
Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration 37
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 36
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 35
Use of contrast echocardiography for quantitative and qualitative evaluation of myocardial perfusion and pulmonary transit time in healthy dogs 34
Holter monitoring in dogs with mitral regurgitation and different class of heart failure 34
Utility of 12-Lead Electrocardiogram for Differentiating Paroxysmal Supraventricular Tachycardias in Dogs 33
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease 32
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs 29
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease 29
Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats 14
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 8
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 8
Effect of the sampling time on urinary electrolytes following furosemide administration in dogs with myxomatous mitral valve disease 5
Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease 4
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 2
Totale 2.238
Categoria #
all - tutte 8.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 0 0 69 7
2019/2020403 78 75 17 9 17 57 36 24 19 59 8 4
2020/2021142 3 8 12 5 23 13 4 15 29 17 7 6
2021/2022231 33 5 6 14 11 2 6 26 7 15 33 73
2022/2023833 68 84 60 68 69 89 12 63 253 21 24 22
2023/2024367 29 33 23 17 35 97 24 42 22 39 6 0
Totale 2.238